These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 17510508)
1. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. Koga M; Kai H; Yasukawa H; Yamamoto T; Kawai Y; Kato S; Kusaba K; Kai M; Egashira K; Kataoka Y; Imaizumi T Circ Res; 2007 Aug; 101(4):348-56. PubMed ID: 17495225 [TBL] [Abstract][Full Text] [Related]
3. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709 [TBL] [Abstract][Full Text] [Related]
4. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice. Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138 [TBL] [Abstract][Full Text] [Related]
5. [The Fc region of immunoglobulin suppresses atherosclerosis in apolipoprotein E knockout mice]. Yuan ZY; Liu Y; Kishimoto C; Shioji K; Yokode M; Liu ZQ Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):489-93. PubMed ID: 12887764 [TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151 [TBL] [Abstract][Full Text] [Related]
7. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation. Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266 [TBL] [Abstract][Full Text] [Related]
8. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice. Desai A; Zhao Y; Warren JS Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814 [TBL] [Abstract][Full Text] [Related]
9. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes. Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699 [TBL] [Abstract][Full Text] [Related]
10. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241 [TBL] [Abstract][Full Text] [Related]
11. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis. Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558 [TBL] [Abstract][Full Text] [Related]